Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXHL2000213	JNJ-53718678口服混悬液	rilematovir	Suspension	Chemical Drugs(1)	Import Drug Application	2020-07-17	强生（中国）投资有限公司	Johnson & Johnson (CHINA) Investment Ltd;Janssen Research & Development LLC	In Review	2020-07-16	view
JXHL2000236	JNJ-53718678口服混悬液	rilematovir	Suspension	Chemical Drugs(1)	Import Drug Application	2020-08-24	强生（中国）投资有限公司	Johnson & Johnson (CHINA) Investment Ltd;Janssen Sciences Ireland Uc	In Review	2020-08-21	view
JXHL2000297	JNJ-53718678口服混悬液	rilematovir	Suspension	Chemical Drugs(1)	Import Drug Application	2020-11-09	强生（中国）投资有限公司	Johnson & Johnson (CHINA) Investment Ltd;Janssen Research & Development LLC	In Review	2020-11-07	view
JXHB2101039	JNJ-53718678口服混悬液	rilematovir	Suspension	Chemical Drugs(1)	Supplementary Application	2021-07-16		Janssen Research & Development LLC			view